BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11888667)

  • 1. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
    Ge X; Fu YM; Meadows GG
    Cancer Lett; 2002 May; 179(2):133-40. PubMed ID: 11888667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice.
    Horiuchi H; Kawamata H; Furihata T; Omotehara F; Hori H; Shinagawa Y; Ohkura Y; Tachibana M; Yamazaki T; Ajiki T; Kuroda Y; Fujimori T
    J Exp Clin Cancer Res; 2004 Dec; 23(4):599-606. PubMed ID: 15743030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
    Denkert C; Siegert A; Leclere A; Turzynski A; Hauptmann S
    Clin Exp Metastasis; 2002; 19(1):79-85. PubMed ID: 11918086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
    Fukazawa H; Uehara Y
    Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT; Schmidt CM
    Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway.
    Brogley MA; Cruz M; Cheung HS
    J Cell Physiol; 1999 Aug; 180(2):215-24. PubMed ID: 10395291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
    Thant AA; Nawa A; Kikkawa F; Ichigotani Y; Zhang Y; Sein TT; Amin AR; Hamaguchi M
    Clin Exp Metastasis; 2000; 18(5):423-8. PubMed ID: 11467775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
    Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
    Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.
    Kadri Z; Petitfrère E; Boudot C; Freyssinier JM; Fichelson S; Mayeux P; Emonard H; Hornebeck W; Haye B; Billat C
    Cell Growth Differ; 2000 Nov; 11(11):573-80. PubMed ID: 11095246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor induces the expression of matrix metalloproteinase-3 in human periodontal ligament cells through the MEK2 mitogen-activated protein kinase pathway.
    Shimazu A; Morishita M
    J Periodontal Res; 2003 Apr; 38(2):122-9. PubMed ID: 12608905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells.
    Lasithiotakis KG; Sinnberg TW; Schittek B; Flaherty KT; Kulms D; Maczey E; Garbe C; Meier FE
    J Invest Dermatol; 2008 Aug; 128(8):2013-23. PubMed ID: 18323781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
    Tan X; Egami H; Abe M; Nozawa F; Hirota M; Ogawa M
    J Clin Pathol; 2005 Dec; 58(12):1242-8. PubMed ID: 16311341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
    Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
    Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
    Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.